Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. / Poulsen, S S; Thulesen, J; Hartmann, B; Kissow, Hannelouise; Nexø, Ebba; Thim, L.

I: Regulatory Peptides, Bind 115, Nr. 2, 2003, s. 91-99.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Poulsen, SS, Thulesen, J, Hartmann, B, Kissow, H, Nexø, E & Thim, L 2003, 'Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats', Regulatory Peptides, bind 115, nr. 2, s. 91-99.

APA

Poulsen, S. S., Thulesen, J., Hartmann, B., Kissow, H., Nexø, E., & Thim, L. (2003). Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regulatory Peptides, 115(2), 91-99.

Vancouver

Poulsen SS, Thulesen J, Hartmann B, Kissow H, Nexø E, Thim L. Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regulatory Peptides. 2003;115(2):91-99.

Author

Poulsen, S S ; Thulesen, J ; Hartmann, B ; Kissow, Hannelouise ; Nexø, Ebba ; Thim, L. / Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. I: Regulatory Peptides. 2003 ; Bind 115, Nr. 2. s. 91-99.

Bibtex

@article{75fd05d074c411dbbee902004c4f4f50,
title = "Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats",
abstract = "Peptides of the trefoil factor family (TFF1, TFF2 and TFF3) are co-secreted with mucus in most organ systems and are believed to interact with mucins to produce high-viscosity, stable gel complexes. We have previously demonstrated that cells in the GI tract possess binding sites to TFF2 and that injected TFF2 ends up in the mucus layer. In the present study, tissue binding and metabolism of parenterally administered human TFF1 and TFF3 in rats were described and compared to the immunohistochemical localization of the TFF peptides. 125I-TFF1 monomer and 125I-TFF3 mono- and dimer were given intravenously to female Wistar rats. The tissue distribution was assessed by gamma counting of organ samples and by autoradiography of histological sections. The degradation of 125I-TFF3 was studied by means of trichloracetic acid (TCA) precipitation and the saturability of the binding by administration of excess unlabelled peptide. The TFF peptides were localized in histologic sections from the GI tract by immunohistochemistry. Injected TFF3 dimer (12{\%}) was taken up by the GI tract. At autoradiography, grains were localized to the same cells that were immunoreactive to TFF2. The binding could be displaced by excess TFF3. Similar binding was observed for the TFF1 and TFF3 monomers apart from binding in the stomach, where the uptake was only 15{\%} in comparison to the dimer. There was no specific binding outside the GI tract and no binding to TFF1 or TFF3 immunoreactive cells. In conclusion, the TFF2-binding cells in the gastrointestinal tract seem to have basolateral, receptor-like activity to all three TFF peptides. The mucous neck cells of the stomach predominantly take up TFFs with two trefoil domains, indicating a different receptor-like activity in the stomach compared to the rest of the GI tract.",
keywords = "Animals, Cells, Cultured, Digestive System, Estrogens, Female, Growth Inhibitors, Humans, Immunoenzyme Techniques, Injections, Intravenous, Iodine Radioisotopes, Mucins, Muscle Proteins, Neuropeptides, Peptide Fragments, Peptides, Proteins, Rats, Rats, Wistar, Tissue Distribution, Tumor Suppressor Proteins",
author = "Poulsen, {S S} and J Thulesen and B Hartmann and Hannelouise Kissow and Ebba Nex{\o} and L Thim",
year = "2003",
language = "English",
volume = "115",
pages = "91--99",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats

AU - Poulsen, S S

AU - Thulesen, J

AU - Hartmann, B

AU - Kissow, Hannelouise

AU - Nexø, Ebba

AU - Thim, L

PY - 2003

Y1 - 2003

N2 - Peptides of the trefoil factor family (TFF1, TFF2 and TFF3) are co-secreted with mucus in most organ systems and are believed to interact with mucins to produce high-viscosity, stable gel complexes. We have previously demonstrated that cells in the GI tract possess binding sites to TFF2 and that injected TFF2 ends up in the mucus layer. In the present study, tissue binding and metabolism of parenterally administered human TFF1 and TFF3 in rats were described and compared to the immunohistochemical localization of the TFF peptides. 125I-TFF1 monomer and 125I-TFF3 mono- and dimer were given intravenously to female Wistar rats. The tissue distribution was assessed by gamma counting of organ samples and by autoradiography of histological sections. The degradation of 125I-TFF3 was studied by means of trichloracetic acid (TCA) precipitation and the saturability of the binding by administration of excess unlabelled peptide. The TFF peptides were localized in histologic sections from the GI tract by immunohistochemistry. Injected TFF3 dimer (12%) was taken up by the GI tract. At autoradiography, grains were localized to the same cells that were immunoreactive to TFF2. The binding could be displaced by excess TFF3. Similar binding was observed for the TFF1 and TFF3 monomers apart from binding in the stomach, where the uptake was only 15% in comparison to the dimer. There was no specific binding outside the GI tract and no binding to TFF1 or TFF3 immunoreactive cells. In conclusion, the TFF2-binding cells in the gastrointestinal tract seem to have basolateral, receptor-like activity to all three TFF peptides. The mucous neck cells of the stomach predominantly take up TFFs with two trefoil domains, indicating a different receptor-like activity in the stomach compared to the rest of the GI tract.

AB - Peptides of the trefoil factor family (TFF1, TFF2 and TFF3) are co-secreted with mucus in most organ systems and are believed to interact with mucins to produce high-viscosity, stable gel complexes. We have previously demonstrated that cells in the GI tract possess binding sites to TFF2 and that injected TFF2 ends up in the mucus layer. In the present study, tissue binding and metabolism of parenterally administered human TFF1 and TFF3 in rats were described and compared to the immunohistochemical localization of the TFF peptides. 125I-TFF1 monomer and 125I-TFF3 mono- and dimer were given intravenously to female Wistar rats. The tissue distribution was assessed by gamma counting of organ samples and by autoradiography of histological sections. The degradation of 125I-TFF3 was studied by means of trichloracetic acid (TCA) precipitation and the saturability of the binding by administration of excess unlabelled peptide. The TFF peptides were localized in histologic sections from the GI tract by immunohistochemistry. Injected TFF3 dimer (12%) was taken up by the GI tract. At autoradiography, grains were localized to the same cells that were immunoreactive to TFF2. The binding could be displaced by excess TFF3. Similar binding was observed for the TFF1 and TFF3 monomers apart from binding in the stomach, where the uptake was only 15% in comparison to the dimer. There was no specific binding outside the GI tract and no binding to TFF1 or TFF3 immunoreactive cells. In conclusion, the TFF2-binding cells in the gastrointestinal tract seem to have basolateral, receptor-like activity to all three TFF peptides. The mucous neck cells of the stomach predominantly take up TFFs with two trefoil domains, indicating a different receptor-like activity in the stomach compared to the rest of the GI tract.

KW - Animals

KW - Cells, Cultured

KW - Digestive System

KW - Estrogens

KW - Female

KW - Growth Inhibitors

KW - Humans

KW - Immunoenzyme Techniques

KW - Injections, Intravenous

KW - Iodine Radioisotopes

KW - Mucins

KW - Muscle Proteins

KW - Neuropeptides

KW - Peptide Fragments

KW - Peptides

KW - Proteins

KW - Rats

KW - Rats, Wistar

KW - Tissue Distribution

KW - Tumor Suppressor Proteins

M3 - Journal article

C2 - 12972324

VL - 115

SP - 91

EP - 99

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2

ER -

ID: 113682